Pulmonary and Critical Care Considerations for E-Cigarette, or Vaping, Product Use-Associated Lung Injury. Read more about Pulmonary and Critical Care Considerations for E-Cigarette, or Vaping, Product Use-Associated Lung Injury.
Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort. Read more about Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.
Lung Transplantation for Patients With COVID-19. Read more about Lung Transplantation for Patients With COVID-19.
Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function. Read more about Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
Cigarette Smoking and ARDS After Blunt Trauma: The Influence of Changing Smoking Patterns and Resuscitation Practices. Read more about Cigarette Smoking and ARDS After Blunt Trauma: The Influence of Changing Smoking Patterns and Resuscitation Practices.
Military Deployment and Respiratory Symptoms: Some Answers, Many Questions. Read more about Military Deployment and Respiratory Symptoms: Some Answers, Many Questions.
Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis. Read more about Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis.
Pirfenidone-Induced Sarcoid-Like Reaction: A Novel Complication. Read more about Pirfenidone-Induced Sarcoid-Like Reaction: A Novel Complication.
Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD. Read more about Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD.
Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model. Read more about Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model.
